These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

795 related articles for article (PubMed ID: 29850629)

  • 21. Autoimmunity in Parkinson's Disease: The Role of α-Synuclein-Specific T Cells.
    Garretti F; Agalliu D; Lindestam Arlehamn CS; Sette A; Sulzer D
    Front Immunol; 2019; 10():303. PubMed ID: 30858851
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer's and Parkinson's diseases.
    Hashimoto M; Rockenstein E; Crews L; Masliah E
    Neuromolecular Med; 2003; 4(1-2):21-36. PubMed ID: 14528050
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroinflammation in Parkinson's disease: is there sufficient evidence for mechanism-based interventional therapy?
    Tansey MG; Frank-Cannon TC; McCoy MK; Lee JK; Martinez TN; McAlpine FE; Ruhn KA; Tran TA
    Front Biosci; 2008 Jan; 13():709-17. PubMed ID: 17981581
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunomodulation as a neuroprotective and therapeutic strategy for Parkinson's disease.
    Olson KE; Gendelman HE
    Curr Opin Pharmacol; 2016 Feb; 26():87-95. PubMed ID: 26571205
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peripheral Immunity, Immunoaging and Neuroinflammation in Parkinson's Disease.
    Kustrimovic N; Marino F; Cosentino M
    Curr Med Chem; 2019; 26(20):3719-3753. PubMed ID: 30306855
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Parkinson's disease and alpha synuclein: is Parkinson's disease a prion-like disorder?
    Olanow CW; Brundin P
    Mov Disord; 2013 Jan; 28(1):31-40. PubMed ID: 23390095
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alpha-synuclein, Parkinson's disease, and Alzheimer's disease.
    Kim S; Seo JH; Suh YH
    Parkinsonism Relat Disord; 2004 May; 10 Suppl 1():S9-13. PubMed ID: 15109581
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of the Neurodegenerative Process Associated to Parkinson's Disease by CD4+ T-cells.
    González H; Contreras F; Pacheco R
    J Neuroimmune Pharmacol; 2015 Dec; 10(4):561-75. PubMed ID: 26018603
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Applying chaperones to protein-misfolding disorders: molecular chaperones against α-synuclein in Parkinson's disease.
    Chaari A; Hoarau-Véchot J; Ladjimi M
    Int J Biol Macromol; 2013 Sep; 60():196-205. PubMed ID: 23748003
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Virus-induced brain pathology and the neuroinflammation-inflammation continuum: the neurochemists view.
    Sian-Hulsmann J; Riederer P
    J Neural Transm (Vienna); 2024 Dec; 131(12):1429-1453. PubMed ID: 38261034
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Innate Immunity and Neurodegeneration.
    Labzin LI; Heneka MT; Latz E
    Annu Rev Med; 2018 Jan; 69():437-449. PubMed ID: 29106805
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Innate and adaptive immune responses in Parkinson's disease.
    Schonhoff AM; Williams GP; Wallen ZD; Standaert DG; Harms AS
    Prog Brain Res; 2020; 252():169-216. PubMed ID: 32247364
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A molecular pathway of neurodegeneration linking alpha-synuclein to ApoE and Abeta peptides.
    Gallardo G; Schlüter OM; Südhof TC
    Nat Neurosci; 2008 Mar; 11(3):301-8. PubMed ID: 18297066
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Screening of innate immune receptors in neurodegenerative diseases: a similar pattern.
    Letiembre M; Liu Y; Walter S; Hao W; Pfander T; Wrede A; Schulz-Schaeffer W; Fassbender K
    Neurobiol Aging; 2009 May; 30(5):759-68. PubMed ID: 17905482
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neurodegenerative diseases: The immunological perspective.
    Molteni M; Rossetti C
    J Neuroimmunol; 2017 Dec; 313():109-115. PubMed ID: 29153601
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apoptosis and Parkinson's disease.
    Lev N; Melamed E; Offen D
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Apr; 27(2):245-50. PubMed ID: 12657363
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The regulatory role of α-synuclein and parkin in neuronal cell apoptosis; possible implications for the pathogenesis of Parkinson's disease.
    Yasuda T; Mochizuki H
    Apoptosis; 2010 Nov; 15(11):1312-21. PubMed ID: 20221696
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune-mediated processes in neurodegeneration: where do we stand?
    Fakhoury M
    J Neurol; 2016 Sep; 263(9):1683-701. PubMed ID: 26872669
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of T cells in the pathogenesis of Parkinson's disease.
    Chen Z; Chen S; Liu J
    Prog Neurobiol; 2018 Oct; 169():1-23. PubMed ID: 30114440
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of neuroinflammation on the pathogenesis of Parkinson's disease.
    Chung YC; Ko HW; Bok E; Park ES; Huh SH; Nam JH; Jin BK
    BMB Rep; 2010 Apr; 43(4):225-32. PubMed ID: 20423606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.